Trump highlights ibogaine development push, Psyence BioMed responds Aug 18, 2026 05:25PM
Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development Aug 18, 2026 05:23PM
Psyence BioMed executives to visit US for ibogaine research meetings May 15, 2026 09:15AM
Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing May 15, 2026 09:15AM